文献速递显微修复重建颅颌面外科

最年轻的全脸复合组织移植:面向年轻人群的血管化复合异体移植模型

Youngest Composite Full-Face Transplant: A Model for Vascularized Composite Allograft in Younger Populations.
PubMed 文献 · Ann Plast Surg · 2022-01-01

本文报告一例18岁女性因中央面部及颅颌面结构完全毁损,在21岁时(2017年5月4日)接受全脸移植,受者手术总时长26小时,无重大围手术期并发症,术后接受3次修整手术,日常生活基本完全独立,仅发生1次II级以上排斥反应并经短期增加免疫抑制成功治疗;作者认为该方案可为年轻人群血管化复合异体移植提供模型。

要点

  • 受者21岁时于2017年5月4日接受全脸移植,受者手术总时长26小时。
  • 无重大围术期并发症,术后接受3次修整手术,日常生活基本完全独立。
  • 仅1次II级以上排斥反应,经短期增加免疫抑制成功治疗。

核心结论

  • 与实体器官移植中年轻与排斥风险增加相关的数据相反,作者现行免疫抑制方案结合该患者依从性仅导致1次II级以上排斥反应。
  • 作者认为该成功移植可作为未来年轻人群血管化复合异体移植的模型。

研究设计与样本

  • 单例病例报告:一名18岁女性表现为中央面部及颅颌面结构完全毁损,合并垂体、视轴和运动控制等重大损伤。
  • 经广泛康复与重建技术后,患者于2017年5月4日在21岁时接受全脸移植。

主要发现

  • 受者手术总时长26小时,无重大围术期并发症。
  • 移植后患者接受3次修整手术,从日常生活活动角度看接近完全独立。
  • 患者发生1次II级以上排斥反应,经短期增加免疫抑制成功治疗。

关键数值与推荐

  • 排斥反应分级:1次II级以上排斥反应,经短期增加免疫抑制成功治疗。

临床怎么用

  • 作者认为该成功移植可作为未来年轻人群血管化复合异体移植的模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The field of face transplantation continues to evolve, with more complex defects being addressed, and, at the same time, increased outcome expectations. Given our unique long-term experience in this field, we consented one of the youngest patients to undergo a full-face transplant. METHODS: An 18-year-old woman presented with complete destruction of her central face and craniofacial structures. She had coexisting major injuries, including pituitary gland, visual axis, and motor control. After extensive rehabilitation and reconstruction techniques, the patient underwent face transplant on May 4, 2017, at the age of 21 years. RESULTS: The total operative time for the recipient was 26 hours. There were no major perioperative complications. Since transplant, the patient has undergone 3 revision surgeries. She is near completely independent from a daily life activity standpoint. She has had 1 episode of rejection above grade II that was successfully treated with a short-term increased in immunosuppression. CONCLUSIONS: Contrary to data in solid organ transplantation where youth is associated with increased risk of rejection, our current algorithm in immunosuppression, combined with this patient's compliance, has led to only 1 rejection episode beyond grade II. This successful transplant can serve as a model for future vascularized composite transplants in younger populations.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Knackstedt R, Siemionow M, Djohan R, et al. Youngest Composite Full-Face Transplant: A Model for Vascularized Composite Allograft in Younger Populations. Ann Plast Surg. 2022. PMID: 36279583. doi:10.1097/SAP.0000000000003312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。